home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Susceptibility To SARS Infection

 
  December, 27 2005 7:03
your information resource in human molecular genetics
 
     
A new study in the January issue of Nature Genetics reports that individuals with particular combinations of genetic variants are less susceptible to infection by the SARS virus. SARS is an acute respiratory disease resulting from infection of a coronavirus, SARS-CoV.

The authors examined 285 individuals with SARS infection from the 2003 outbreak in Hong Kong, as well as 3 control groups of individuals not infected with SARS. The study found that those individuals with particular combinations of repeats in the extracellular region of a receptor molecule known as L-SIGN, previously shown to bind to the SARS-CoV, show a reduced risk of infection. L-SIGN has also previously been shown to bind the viruses HIV and SIV, and is involved with mediating infection of these viruses, as well as the bacterium M. tuberculosis. This identification provides insight into the mechanism by which SARS-CoV infects a human host, and may help to understand better the nature of the SARS epidemic within these regions.

Author Contact:

Chen-Lung S Lin (The University of Hong Kong, China)
E-mail: clin@hkucc.hku.hk

Abstract available online.

(C) Nature Genetics press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.